NCT00365105
Clinical Trial Information
Trial Number: NCT00365105 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Miscellaneous
- Lung, Mediastinal and Pleural Neoplasm - Miscellaneous
- Reproductive System Neoplasm, Male - Prostate Cancer
Trial Title:
Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases From Lung, Breast, and Prostate Cancer
Study ID:
RTOG-0517
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00365105-D2 | Data submissions NCT00365105-D1 and NCT00365105-D2 contain patient-reported acute toxicity and health-related quality of life (QOL) data from trial NCT00365105 to reproduce results PubMed ID=30094545. |
| NCT00365105-D1 | Data submissions NCT00365105-D1 and NCT00365105-D2 contain patient-reported acute toxicity and health-related quality of life (QOL) data from trial NCT00365105 to reproduce results PubMed ID=30094545. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®